Pliant Therapeutics, Inc. (PLRX)
NASDAQ · Manufacturing · Pharmaceutical preparations
PLRX price, last 12 months
Key stats
- Previous close
- $0.6610
- Open
- $0.6535
- Day range
- $0.6000 – $0.6568
- 52-week range
- $0.5719 – $1.67
- Volume
- 746.8K
- Avg volume (20 days)
- 430.9K
- Market cap
- $43.2M
Performance
Technicals and fundamentals
About Pliant Therapeutics, Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $43.2M